Preserved T cell reactivity to the SARS-CoV-2 Omicron variant indicates continued protection in vaccinated individuals.
L. De Marco, S. D'Orso, M. Pirronello, A. Verdiani, A. Termine, C. Fabrizio, A. Capone, A. Sabatini, G. Guerrera, R. Placido, M. Sambucci, D. F. Angelini, F. Giannessi, M. Picozza, C. Caltagirone, , G. Borsellino
The study assesses T cell reactivity to the SARS-CoV-2 Omicron variant in vaccinated individuals and finds reduced recognition of mutated Spike regions but preserved overall reactivity.
bioRxiv · Dec 30, 2021Immunology